Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in June 2015 on request of the sponsor.
On 3 December 2008, orphan designation (EU/3/08/584) was granted by the European Commission to Ziopharm Oncology Limited, United Kingdom, for palifosfamide for the treatment of soft tissue sarcoma.
|Disease / condition||
Treatment of soft tissue sarcoma
|Date of decision||
|Orphan decision number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.